Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
100%(7 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_2
7
88%

Phase Distribution

0

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
7(87.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 27 (87.5%)
N/A1 (12.5%)

Trials by Status

withdrawn113%
completed788%

Recent Activity

0 active trials
Showing 5 of 8
withdrawnphase_2

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

NCT00964951
completednot_applicable

Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus

NCT01023711
completedphase_2

Novartis H1N1 Vaccine in Pregnant Women

NCT00992719
completedphase_2

Sanofi Pasteur, TIV + H1N1, Pediatric Population

NCT00943202
completedphase_2

H1N1 Vaccine in Pregnant Women

NCT00963430
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00964951Phase 2

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Withdrawn
NCT01023711Not Applicable

Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus

Completed
NCT00992719Phase 2

Novartis H1N1 Vaccine in Pregnant Women

Completed
NCT00943202Phase 2

Sanofi Pasteur, TIV + H1N1, Pediatric Population

Completed
NCT00963430Phase 2

H1N1 Vaccine in Pregnant Women

Completed
NCT00943631Phase 2

Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations

Completed
NCT00943488Phase 2

CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations

Completed
NCT00943878Phase 2

Sanofi H1N1 + TIV - Adults and Elderly

Completed

All 8 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8